z-logo
HomeZAIABlog
open-access-imgOpen Access
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
Author(s) -
Terence C. Chua,
Daniel L. Chan,
Archana Rao,
David L. Morris
Publication year - 2012
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s31070
Subject(s) - medicine , ovarian cancer , chemotherapy , survival rate , hyperthermic intraperitoneal chemotherapy , surgery , cancer , oncology , cytoreductive surgery
TO REVIEW THE TWO MAIN APPROACHES OF INTRAPERITONEAL (IP) CHEMOTHERAPY DELIVERY IN OVARIAN CANCER: postoperative adjuvant IP chemotherapy after cytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.